Pharma

Britain's Royal College of Nursing severed commercial ties with Teva UK under activist pressure, while the Israeli pharmaceutical giant continues robust financial growth and pipeline advancements.

Israeli startup Remepy has raised $36 million in a Series A funding round. The company is developing "hybrid drugs" that combine traditional medication with digital code to enhance treatment efficacy.